Krystal Biotech, Inc. (KRYS) Revenue History
Krystal Biotech, Inc. (KRYS) annual revenue history. Get revenue data in Excel with MarketXLS.
Revenue Data
| Period | Revenue (USD) |
|---|---|
| 2017-12-31 | N/A |
| 2019-12-31 | N/A |
| 2020-12-31 | N/A |
| 2021-12-31 | N/A |
| 2022-12-31 | N/A |
| 2023-12-31 | $50.70M |
| 2024-12-31 | $290.51M |
| 2025-12-31 | $389.13M |
How KRYS compares with sector peers
| Symbol | Company | Revenue (latest fiscal year) |
|---|---|---|
| MNKD | MannKind Corporation | $348.97M |
| FLGT | Fulgent Genetics Inc. | $322.67M |
| EOLS | Evolus Inc. | $297.18M |
| RIGL | Rigel Pharmaceuticals Inc. | $294.28M |
| VCEL | Vericel Corporation | $276.26M |
These are five companies in the same sector as KRYS with a comparable annual revenue. Each figure above is that company's most recent completed fiscal year, read from the same annual statements as the table on its own page, so the period end dates can differ between rows.
Get Krystal Biotech, Inc. Data in Excel
Stream real-time stock prices and financials directly into your spreadsheets with MarketXLS.
Try: =hf_Revenue("KRYS", 2024)
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Volume |
| 2 | KRYS | $359.76 | +1.00% | 0.28M |
| 3 | ||||
| 4 | ||||
| 5 |